WESTPAC BANKING CORP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
WESTPAC BANKING CORP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2023$420,800
-18.0%
6,9970.0%0.01%
-25.0%
Q4 2022$513,230
-99.9%
6,9970.0%0.01%0.0%
Q3 2022$531,632,000
+9.3%
6,9970.0%0.01%
+33.3%
Q2 2022$486,292,000
-16.1%
6,9970.0%0.01%
-14.3%
Q1 2022$579,701,000
+10.3%
6,9970.0%0.01%
+40.0%
Q4 2021$525,335,000
-35.4%
6,9970.0%0.01%
-44.4%
Q3 2021$812,841,000
-47.6%
6,9970.0%0.01%
-43.8%
Q2 2021$1,552,075,000
+28.2%
6,9970.0%0.02%
+14.3%
Q4 2020$1,210,761,0006,9970.01%
Other shareholders
NOVOCURE LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders